ITPR2(肌醇1,4,5-三磷酸受体2型)属于肌醇三磷酸受体(ITPR)基因家族,该家族包括ITPR1、ITPR2和ITPR3三个成员,共同编码细胞内钙离子释放通道的关键组成部分。ITPR家族蛋白主要位于内质网膜上,通过响应肌醇1,4,5-三磷酸(IP3)信号介导钙离子从内质网释放到胞质,参与调控钙信号通路。ITPR2主要在非神经元组织中高表达,如肝脏、胰腺和免疫细胞,其功能涉及代谢调节、分泌活动和免疫反应。ITPR2蛋白的特点是具有IP3结合域、钙离子通道域和调节域,其活性受钙离子浓度、ATP和蛋白质相互作用的精细调控。突变或功能异常可能导致钙信号紊乱,与多种疾病相关。例如,ITPR2突变与吉尔伯特综合征(一种轻度高胆红素血症)有关,可能影响肝脏胆红素代谢。此外,ITPR2异常表达还涉及某些癌症(如乳腺癌和结直肠癌)的进展,因其钙信号失调可促进细胞增殖和迁移。ITPR2过表达可能导致细胞内钙离子持续升高,引发钙超载相关的细胞凋亡或异常增殖,而表达降低则可能削弱钙信号传导,影响分泌功能(如胰岛素释放)或免疫细胞激活。在基因家族层面,ITPR成员虽结构相似,但组织分布和调控特性各异:ITPR1主导神经元和心脏功能,ITPR3常见于外分泌组织,而ITPR2更多参与外周组织代谢。研究ITPR2有助于理解钙依赖性疾病的机制,并为相关治疗(如代谢紊乱或癌症)提供潜在靶点。
The protein encoded by this gene belongs to the inositol 1,4,5-triphosphate receptor family, whose members are second messenger intracellular calcium release channels. These proteins mediate a rise in cytoplasmic calcium in response to receptor activated production of inositol triphosphate. Inositol triphosphate receptor-mediated signaling is involved in many processes including cell migration, cell division, smooth muscle contraction, and neuronal signaling. This protein is a type 2 receptor that consists of a cytoplasmic amino-terminus that binds inositol triphosphate, six membrane-spanning helices that contribute to the ion pore, and a short cytoplasmic carboxy-terminus. A mutation in this gene has been associated with anhidrosis, suggesting that intracellular calcium release mediated by this protein is required for eccrine sweat production. [provided by RefSeq, Apr 2015]
由该基因编码的蛋白质属于1,4,5-三磷酸肌醇受体家族,其成员是第二信使的细胞内钙释放通道。这些蛋白质调解胞浆钙上升响应受体激活产生三磷酸肌醇。三磷酸肌醇受体介导的信号传导涉及许多过程,包括细胞迁移,细胞分裂,平滑肌收缩,和神经信号。该蛋白是一个类型2受体,它由一个细胞质氨基末端结合肌醇三磷酸,六跨膜螺旋,有助于离子孔隙,和一个短的胞质羧基末端。在这个基因的突变已与无汗相关联,这表明此蛋白质介导的细胞内钙释放所??需的汗腺汗液产生。 [由RefSeq的,2015年4月提供]
ITPR2基因(以及对应的蛋白质)的细胞分布位置:
ITPR2基因的本体(GO)信息:
名称 |
---|
4020 Calcium signaling pathway [PATH:hsa04020] |
4070 Phosphatidylinositol signaling system [PATH:hsa04070] |
4022 cGMP - PKG signaling pathway [PATH:hsa04022] |
4114 Oocyte meiosis [PATH:hsa04114] |
4540 Gap junction [PATH:hsa04540] |
4611 Platelet activation [PATH:hsa04611] |
4922 Glucagon signaling pathway [PATH:hsa04922] |
4912 GnRH signaling pathway [PATH:hsa04912] |
4915 Estrogen signaling pathway [PATH:hsa04915] |
4921 Oxytocin signaling pathway [PATH:hsa04921] |
4918 Thyroid hormone synthesis [PATH:hsa04918] |
4270 Vascular smooth muscle contraction [PATH:hsa04270] |
4970 Salivary secretion [PATH:hsa04970] |
4971 Gastric acid secretion [PATH:hsa04971] |
4972 Pancreatic secretion [PATH:hsa04972] |
4724 Glutamatergic synapse [PATH:hsa04724] |
4725 Cholinergic synapse [PATH:hsa04725] |
4728 Dopaminergic synapse [PATH:hsa04728] |
4726 Serotonergic synapse [PATH:hsa04726] |
4720 Long-term potentiation [PATH:hsa04720] |
4730 Long-term depression [PATH:hsa04730] |
4723 Retrograde endocannabinoid signaling [PATH:hsa04723] |
4750 Inflammatory mediator regulation of TRP channels [PATH:hsa04750] |
5205 Proteoglycans in cancer [PATH:hsa05205] |
5010 Alzheimer's disease [PATH:hsa05010] |
名称 |
---|
Adaptive Immune System |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers |
beta-catenin independent WNT signaling |
C-type lectin receptors (CLRs) |
Ca2+ pathway |
CLEC7A (Dectin-1) induces NFAT activation |
CLEC7A (Dectin-1) signaling |
DAG and IP3 signaling |
DAP12 interactions |
DAP12 signaling |
Downstream signal transduction |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
Effects of PIP2 hydrolysis |
EGFR interacts with phospholipase C-gamma |
Elevation of cytosolic Ca2+ levels |
Fc epsilon receptor (FCERI) signaling |
FCERI mediated Ca+2 mobilization |
Fcgamma receptor (FCGR) dependent phagocytosis |
G alpha (q) signalling events |
G-protein mediated events |
Gastrin-CREB signalling pathway via PKC and MAPK |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion |
GPCR downstream signaling |
Hemostasis |
Immune System |
Innate Immune System |
Integration of energy metabolism |
Metabolism |
NGF signalling via TRKA from the plasma membrane |
Opioid Signalling |
Phospholipase C-mediated cascade; FGFR2 |
Phospholipase C-mediated cascade; FGFR3 |
Phospholipase C-mediated cascade; FGFR4 |
Phospholipase C-mediated cascade: FGFR1 |
Platelet activation, signaling and aggregation |
Platelet calcium homeostasis |
Platelet homeostasis |
PLC beta mediated events |
PLC-gamma1 signalling |
PLCG1 events in ERBB2 signaling |
Regulation of insulin secretion |
Role of phospholipids in phagocytosis |
Signal Transduction |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by FGFR |
Signaling by FGFR1 |
Signaling by FGFR2 |
Signaling by FGFR3 |
Signaling by FGFR4 |
Signaling by GPCR |
Signaling by PDGF |
Signaling by the B Cell Receptor (BCR) |
Signaling by VEGF |
Signaling by Wnt |
Signalling by NGF |
VEGFA-VEGFR2 Pathway |
VEGFR2 mediated cell proliferation |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
ANHIDROSIS, FAMILIAL GENERALIZED, WITH NORMAL SWEAT GLANDS | 0.32 | 1 | 1 | CLINVAR_MGD_UNIPROT |
Kashin-Beck Disease | 0.120271442 | 1 | 1 | BeFree_GWASCAT |
Cardiomegaly | 0.12 | 1 | 0 | CTD_human |
Brain Hypoxia | 0.12 | 1 | 0 | CTD_human |
Amyotrophic Lateral Sclerosis | 0.007729856 | 2 | 1 | BeFree_GAD_LHGDN |
Tobacco Use Disorder | 0.004734064 | 2 | 0 | GAD |
Rheumatoid Arthritis | 0.00272435 | 1 | 0 | LHGDN |
Systemic arterial pressure | 0.002367032 | 1 | 0 | GAD |
Blood pressure finding | 0.002367032 | 1 | 0 | GAD |
Amyotrophic Lateral Sclerosis, Sporadic | 0.001085767 | 4 | 5 | BeFree |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。